IRIS MELANOMA

Clinical trials for IRIS MELANOMA explained in plain language.

Never miss a new study

Get alerted when new IRIS MELANOMA trials appear

Sign up with your email to follow new studies for IRIS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

Can two existing drugs keep eye cancer from spreading?

Disease control Ongoing

This phase 2 trial tests whether sunitinib or valproic acid can prevent uveal melanoma, a rare eye cancer, from spreading to other parts of the body in high-risk patients. 210 participants who have already had their primary tumor treated are randomly assigned to receive one of th…

Matched conditions: IRIS MELANOMA

Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC

IRIS MELANOMA

Get alerted when new IRIS MELANOMA trials appear

Can two existing drugs keep eye cancer from spreading?